IL‐6: Regulator of Treg/Th17 balance

European Journal of Immunology - Tập 40 Số 7 - Trang 1830-1835 - 2010
Akihiro Kimura1, Tadamitsu Kishimoto1
1Laboratory of Immune Regulation, Osaka University Graduate School of Frontier Biosciences, Osaka, Japan

Tóm tắt

Abstract

IL‐6 is a pleiotropic cytokine involved in the physiology of virtually every organ system. Recent studies have demonstrated that IL‐6 has a very important role in regulating the balance between IL‐17‐producing Th17 cells and regulatory T cells (Treg). The two T‐cell subsets play prominent roles in immune functions: Th17 cell is a key player in the pathogenesis of autoimmune diseases and protection against bacterial infections, while Treg functions to restrain excessive effector T‐cell responses. IL‐6 induces the development of Th17 cells from naïve T cells together with TGF‐β; in contrast, IL‐6 inhibits TGF‐β‐induced Treg differentiation. Dysregulation or overproduction of IL‐6 leads to autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA), in which Th17 cells are considered to be the primary cause of pathology. Given the critical role of IL‐6 in altering the balance between Treg and Th17 cells, controlling IL‐6 activities is potentially an effective approach in the treatment of various autoimmune and inflammatory diseases. Here, we review the role of IL‐6 in regulating Th17/Treg balance and describe the critical functions of IL‐6 and Th17 in immunity and immune‐pathology.

Từ khóa


Tài liệu tham khảo

10.1126/science.8097338

10.1084/jem.178.2.567

10.1084/jem.20040590

10.1038/nature01202

10.1016/0167-5699(88)91308-4

10.4049/jimmunol.164.5.2759

10.1016/j.immuni.2004.08.018

10.1084/jem.20041257

10.1016/S1074-7613(02)00391-6

10.1038/nature06764

10.1084/jem.20030152

10.1038/ni.1818

10.1038/nature04753

10.1038/nature04754

10.1016/j.immuni.2006.01.001

10.1182/blood-2008-05-155846

10.1016/S0140-6736(08)60454-7

10.1038/324073a0

10.1038/332083a0

10.1073/pnas.89.1.232

10.1016/0014-5793(87)80344-7

10.1073/pnas.84.20.7251

10.1038/368339a0

10.1016/0092-8674(90)90411-7

10.1126/science.1411569

10.1126/science.8272873

10.1016/S0168-9525(00)89000-9

10.1016/j.immuni.2004.08.018

10.1016/S1359-6101(03)00002-9

10.1084/jem.194.4.519

10.1136/gut.52.1.65

10.4049/jimmunol.177.1.566

10.4049/jimmunol.171.11.6173

10.2353/ajpath.2008.070690

10.1191/096120300678828703

10.1016/j.cellimm.2005.11.002

10.1038/ni1254

10.1084/jem.20041257

10.4049/jimmunol.168.11.5699

10.1038/nature05970

10.1002/eji.200939487

10.1016/j.cell.2006.07.035

10.1016/j.immuni.2007.11.016

10.4049/jimmunol.0801162

10.4049/jimmunol.178.8.4901

10.1073/pnas.0705268104

10.1038/ni1375

10.4049/jimmunol.177.3.1416

10.1038/ni1376

10.1016/j.immuni.2007.02.009

10.1038/ni1500

10.1084/jem.20052222

10.1073/pnas.0804231105

10.1126/science.1145697

10.1038/nature06880

10.1038/nature06881

10.1111/j.0105-2896.2006.00427.x

10.1084/jem.20030152

10.1038/nm0804-801

10.1111/j.0105-2896.2005.00280.x

10.1111/j.0105-2896.2006.00420.x

10.1038/nature06878

10.1002/art.24126

10.1073/pnas.0802218105

10.1182/blood-2004-12-4602

10.1053/j.gastro.2004.01.012

10.1002/art.27221

10.1002/art.20303

10.1172/JCI5703

10.1186/ar1916